首页 | 本学科首页   官方微博 | 高级检索  
     

亲体部分肝移植治疗小儿肝豆状核变性病
引用本文:张峰,王学浩,李相成,钱建民,陈吉庆,何祚光,孔连宝,王科,张浩,孙倍成,成峰,陆森,胡建平,汤黎明. 亲体部分肝移植治疗小儿肝豆状核变性病[J]. 中华小儿外科杂志, 2002, 23(2): 116-118
作者姓名:张峰  王学浩  李相成  钱建民  陈吉庆  何祚光  孔连宝  王科  张浩  孙倍成  成峰  陆森  胡建平  汤黎明
作者单位:1. 210029,南京医科大学第一附属医院肝脏移植中心
2. 210029,南京医科大学第一附属医院肝脏移植中心儿科
基金项目:江苏省政府重点课题资助项目 (BJ980 2 5 ),江苏省青年基金项目 (BQ980 2 ),江苏省卫生厅重点项目 (H95 17)
摘    要:目的:通过亲体部分肝移植的方法治疗小儿肝豆状核变性病(Wilson‘s病),探讨Wilson‘s病的根治方法。方法:对术前均明确诊断为Wilson‘s病的患儿(男1例,女4例)施行亲体部分肝移植,患儿平均年龄9岁,本组供肝者均为患儿母亲,Child分级:B组4例,C级1例,除1例患儿血型为B型,供体血型为O型外,其余均为供受体血型相同,结合临床资料对本组所有Wilson‘s病患儿进行回顾性分析。结果:所有供,受体手术顺利,术后恢复良好,5例Wilson‘s病患儿术后3周患儿进行回顾性.分析结果:所有供,受体手术顺利,术后恢复良好,5例Wilson‘s病患儿术后3周肝功能恢复正常,复查铜氧化酶均正常,K-F环均不同程度变浅,神经系统症状有所好转,术后并发症,1例出现肝动脉栓塞(术后第6d再次行减体积肝移植),术后分别随访12.5个月,11个月,10个月,9个月和7.5个月,现均已康复出院。结论:亲体部分肝移植是根治Wilson‘s病等代谢性疾病的有效方法。

关 键 词:肝豆状核变性 肝移植 供体 亲体部分肝移植 治疗 儿童
修稿时间:2001-06-14

Preliminary experience of living related liver transplantation for Wilson''''s disease in children
ZHANG Feng,WANG Xuehao,LI Xiangcheng,et al.. Preliminary experience of living related liver transplantation for Wilson''''s disease in children[J]. Chinese Journal of Pediatric Surgery, 2002, 23(2): 116-118
Authors:ZHANG Feng  WANG Xuehao  LI Xiangcheng  et al.
Affiliation:ZHANG Feng,WANG Xuehao,LI Xiangcheng,et al. Liver Transplantation Center,First Affiliated Hospital of Nanjing Medical University,Nanjing 210029,China
Abstract:Objective To investigate LRLT (living related liver transplantation) for Wilson's disease in children.Methods LRLT was performed on 5 children(mean age 9 years) with Wilson's disease (1 male and 4 females).All living donors were mothers.The Child stage were grade B in 4 and grade C in 1.Only 1 recipient blood type was B, donor blood type was O, the other donors and recipients blood types were the same, respectively. A retrospective analysis was made for all cases.Results All donors and recipients recovered satisfactorily. In 5 Wilson's patients, liver graft function and copper oxidase became normal 3 weeks post operatively. Kayser Fleischer ring and nervous system symptom were alleviated to various extents. One patient became complicated hepatic artery thrombosis (reduced size liver transplantation was performed 6?days after the first transplantation ). The patients were followed up for 12.5 ?months, 11?months, 10?months, 9?months and 7.5 ?months respectively.Conclusion LRLT is an effective therapy for Wilson's disease and other metabolic liver diseases.
Keywords:Hepatotenticular degeneration  Liver transplantation  Living donors  survive
本文献已被 CNKI 维普 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号